Latest News
Featured News
Scancell initiates new arm (Cohort 4) in SCOPE Phase 2 study to evaluate intradermal administration and an accelerated dosing regimen for iSCIB1+
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell Appoints Sath Nirmalananthan as Chief Financial Officer
Modi-1 trial open for expansion in combination with checkpoint inhibitors
Extension of exercise period for CEO share options
Pipeline strategy and business update
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Society of Clinical Oncology Meeting
Issue of share options to Non-Executive Directors
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.